Cell Microsystems

Executive Summary

Cell Microsystems is a biotechnology company specializing in automated single-cell isolation and analysis via its proprietary CellRaft platform. This technology enables researchers to image, identify, and physically isolate specific cells or colonies from a shared culture environment, addressing critical needs in cell therapy development, diagnostics, and basic life science research. The platform's ability to handle single-cell workflows with precision positions it well for applications such as CAR-T cell manufacturing, iPSC clone selection, and rare cell detection. As the cell therapy and precision diagnostics markets expand, Cell Microsystems' tools offer scalable solutions for both research and clinical use. The company has established a growing customer base among academic institutions and biopharma, though it remains private and faces competition from established players like 10x Genomics and Berkeley Lights. Continued platform innovation and strategic partnerships will be key to capturing market share. Overall, Cell Microsystems presents a compelling investment opportunity with strong technology underpinnings and significant market tailwinds.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation CellRaft system with higher throughput and automation70% success
• Q4 2026Strategic partnership with a major cell therapy developer for manufacturing integration60% success
• Q1 2027FDA 510(k) clearance for a diagnostic application using CellRaft for rare cell detection50% success